Drug Profile
Research programme: interstitial cystitis therapeutics - Acologix/University of Maryland
Alternative Names: AC-700Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator University of Maryland, Baltimore
- Class Glycoproteins
- Mechanism of Action Antiproliferative factor APF inhibitors; Heparin epidermal growth factor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Interstitial cystitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Interstitial-cystitis in USA
- 28 Feb 2007 AC 700 is available for licensing worldwide(http://www.acologix.com)
- 19 Sep 2006 Preclinical trials in Interstitial cystitis in USA (unspecified route)